CLINICAL_TRIALS
research
· 2024-08-26
Clinical Trial Update: A Registered Cohort Study on FSHD1
Summary
A registered cohort study investigating Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is currently recruiting participants.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ning Wang, MD., PhD. | Conditions: Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) | Status: RECRUITING